4.7 Article

A microRNA upregulated in asthma airway T cells promotes TH2 cytokine production

Journal

NATURE IMMUNOLOGY
Volume 15, Issue 12, Pages 1162-1170

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ni.3026

Keywords

-

Categories

Funding

  1. US National Institutes of Health [HL107202, HL109102]
  2. Sandler Asthma Basic Research Center
  3. Leukemia AMP
  4. Lymphoma Society
  5. US National Science Foundation predoctoral fellowship [2010101500]
  6. Swiss Foundation for Grants in Biology and Medicine [PASMP3-142725]
  7. National Multiple Sclerosis Society
  8. UCSF Program for Breakthrough Biomedical Research
  9. Sandler Foundation
  10. Swiss National Science Foundation (SNF) [PASMP3_142725] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

MicroRNAs (miRNAs) exert powerful effects on immunological function by tuning networks of target genes that orchestrate cell activity. We sought to identify miRNAs and miRNA-regulated pathways that control the type 2 helper T cell (T(H)2 cell) responses that drive pathogenic inflammation in asthma. Profiling miRNA expression in human airway-infiltrating T cells revealed elevated expression of the miRNA miR-19a in asthma. Modulating miR-19 activity altered T(H)2 cytokine production in both human and mouse T cells, and TH2 cell responses were markedly impaired in cells lacking the entire miR-17 similar to 92 cluster. miR-19 promoted T(H)2 cytokine production and amplified inflammatory signaling by direct targeting of the inositol phosphatase PTEN, the signaling inhibitor SOCS1 and the deubiquitinase A20. Thus, upregulation of miR-19a in asthma may be an indicator and a cause of increased T(H)2 cytokine production in the airways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available